Tag Archives: cancer diagnostics

July, 2016

December, 2015

  • 3 December

    MetaStat Presents Positive Data for its Breast Cancer Diagnostic Test

    BOSTON–(BUSINESS WIRE)–MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company, today presented positive results from an analytical validation study demonstrating the analytical accuracy, reproducibility, and precision of its MetaSite Breast™ test at the Tumor Metastasis meeting of the American Association for Cancer Research (AACR) in Austin, Texas. The MetaSite Breast™ test predicts …

May, 2015

  • 11 May

    FDA Clears Roche’s KRAS Mutation Test for Colorectal Cancer Patients

    Today, Roche announced that US health regulators have approved its diagnostic test for a certain gene mutation in patients with advanced colorectal cancer. The company said that the US Food and Drug Administration (FDA) approved the cobas KRAS Mutation Test for diagnostic use. The real-time polymerase chain reaction (PCR) test …

  • 4 May

    Biocept Launches its c-MET Biomarker

    Molecular oncology diagnostics company, Biocept, Inc., is expanding its cancer diagnostic portfolio with the launch of a new liquid biopsy detection test. The company announced the launch of its c-MET amplification detection test utilizing a blood-based “liquid biopsy.” According to the company, the diagnostic assay can potentially help physicians identify …